Timothy A Springer - Net Worth and Insider Trading
Timothy A Springer Net Worth
The estimated net worth of Timothy A Springer is at least $287 Million dollars as of 2024-04-28. Timothy A Springer is the Director, 10% Owner of Morphic Holding Inc and owns about 7,418,960 shares of Morphic Holding Inc (MORF) stock worth over $208 Million. Timothy A Springer is the Director, 10% Owner of Scholar Rock Holding Corp and owns about 3,549,422 shares of Scholar Rock Holding Corp (SRRK) stock worth over $52 Million. Timothy A Springer is also the Director, 10% Owner of Cartesian Therapeutics Inc and owns about 1,287,714 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $27 Million. Details can be seen in Timothy A Springer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy A Springer has not made any transactions after 2024-03-18 and currently still holds the listed stock(s).
Transaction Summary of Timothy A Springer
Timothy A Springer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy A Springer owns 3 companies in total, including Cartesian Therapeutics Inc (RNAC) , Morphic Holding Inc (MORF) , and Scholar Rock Holding Corp (SRRK) .
Click here to see the complete history of Timothy A Springer’s form 4 insider trades.
Insider Ownership Summary of Timothy A Springer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2024-03-18 | director |
| MORF | Morphic Holding Inc | 2023-05-03 | director & 10 percent owner |
| SRRK | Scholar Rock Holding Corp | 2019-09-03 | 10 percent owner |
Timothy A Springer Latest Holdings Summary
Timothy A Springer currently owns a total of 3 stocks. Among these stocks, Timothy A Springer owns 7,418,960 shares of Morphic Holding Inc (MORF) as of May 3, 2023, with a value of $208 Million and a weighting of 72.59%. Timothy A Springer owns 3,549,422 shares of Scholar Rock Holding Corp (SRRK) as of May 29, 2018, with a value of $52 Million and a weighting of 17.98%. Timothy A Springer also owns 1,287,714 shares of Cartesian Therapeutics Inc (RNAC) as of March 18, 2024, with a value of $27 Million and a weighting of 9.44%.
Latest Holdings of Timothy A Springer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MORF | Morphic Holding Inc | 2023-05-03 | 7,418,960 | 28.07 | 208,250,207 |
| SRRK | Scholar Rock Holding Corp | 2018-05-29 | 3,549,422 | 14.53 | 51,573,102 |
| RNAC | Cartesian Therapeutics Inc | 2024-03-18 | 1,287,714 | 21.03 | 27,080,625 |
Holding Weightings of Timothy A Springer
Timothy A Springer Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy A Springer has made a total of 5 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Morphic Holding Inc is the acquisition of 1,050,000 shares on May 3, 2023, which cost Timothy A Springer around $47 Million.
According to the SEC Form 4 filings, Timothy A Springer has made a total of 0 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 71,428 shares on May 29, 2018, which cost Timothy A Springer around $999,992.
According to the SEC Form 4 filings, Timothy A Springer has made a total of 11 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 635 shares on March 18, 2024, which cost Timothy A Springer around $11,426.
Insider Trading History of Timothy A Springer
- 1
Timothy A Springer Trading Performance
GuruFocus tracks the stock performance after each of Timothy A Springer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy A Springer is 9.4%. GuruFocus also compares Timothy A Springer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy A Springer within 3 months outperforms 11 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy A Springer's insider trading performs compared to the benchmark.
Performance of Timothy A Springer
Average Return
0%
Outperforming Transactions
40%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.92 | 9.4 | 11.33 | 0 | -18.32 | -17.25 |
| Relative Return to S&P 500(%) | 13.29 | 4.2 | 3 | -10.53 | -25.34 | -27.4 |
Timothy A Springer Ownership Network
Ownership Network List of Timothy A Springer
Ownership Network Relation of Timothy A Springer
Timothy A Springer Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Timothy A Springer is the director of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Timothy A Springer made 3 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net purchase of 1,223,316. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net sale of 48,524 shares made by Carsten Brunn , a net sale of 12,349 shares made by Peter G Traber , and a net sale of 9,784 shares made by Takashi Kei Kishimoto .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 40,777 shares, with a net purchase of 40,777 shares. During the past 18 months, 2,681 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,096 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Timothy A Springer Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy A Springer. You might contact Timothy A Springer via mailing address: 36 Woodman Road, Chestnut Hill Ma 02467.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
